Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


Regulatory ILCs help control intestinal inflammation

A regulatory subpopulation of innate lymphoid cells (ILCregs) has been reported in a new study published in Cell. Distinct from ILCs and regulatory T cells, ILCregs were identified in both mouse and human intestine samples and had a unique gene identity. Using mouse models of intestinal inflammation (including a variety of inflammatory stimuli: dextran sodium sulfate, anti-CD40 antibody and Salmonella infection), the researchers found that ILCregs contributed to the resolution of innate intestinal inflammation, gradually expanding in numbers in the intestine during the process of inflammation, with peak numbers coinciding with peak inflammation levels. Moreover, ILCregs suppressed the activation of ILC1 and ILC3 subtypes via the secretion of IL-10, with autocrine transforming growth factor β1 required for the expansion and maintenance of ILCregs during inflammation.


  1. 1

    Wang, S. et al. Regulatory innate lymphoid cells control innate intestinal inflammation. Cell 171, 201–216 (2017)

    CAS  Article  Google Scholar 

Download references


Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ray, K. Regulatory ILCs help control intestinal inflammation. Nat Rev Gastroenterol Hepatol 14, 631 (2017).

Download citation


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing